Contains FD&C Yellow No. 5 Lake (Tartrazine) as a color additive.
Formula re: Contains
Ferrex 150 Polysaccharide-Iron complex capsules are a product of ferric iron complexed to a low molecular weight polysaccharide. This polysaccharide is a product of extensive hydrolysis of starch.
Brand IP Statement(s) re: (c), (TM), (SM)
Ferrex 150 is a dark brown powder that forms a very dark brown solution when dissolved in water.
General Statements: All Other Content
It is tasteless and odorless.
Formulation re: Does NOT Contain
As an organic complex, it contains no free irons.
General Statements: All Other Content
Indications and usage: Ferrex 150 may be used for the dietary management of iron deficiencies.
Precautions re: All Other
Contraindications: Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement.
Formula re: Contains
Precautions: This product contains FD&C Yellow No. 5 Lake (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons.
Precautions re: Allergies
Precautions: This product contains FD&C Yellow No. 5 Lake (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons.
Precautions re: Pregnant or Nursing or Prescription Medications
Although the overall incidence of FD&C Yellow No. 5 Lake (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systemic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible.
Precautions re: Pregnant or Nursing or Prescription Medications
Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other.
Precautions re: Children
As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning.
Precautions re: All Other
Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools.
General: Product/Version Code
Re-Order No. 081119 M-29 Rev. 09/11
Formula re: Contains
Polysaccharide-Iron Complex Capsules
FDA Statement of Identity
Dietary Supplement
General Statements: All Other Content
For dispensing purpose only
Precautions re: All Other
Do not use if blister seals are broken
General Statements: All Other Content
10 x 10 Capsules
Precautions re: All Other
To Report Serious Adverse Effects Call: 800-616-2471
Precautions re: Children
Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Major Ferrex-150 | Supplement DB
Precautions re: All Other
Adverse reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient.
Overdose: The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemic, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
Suggested/Recommended/Usage/Directions
Dosage and administration: Adults: One or two capsules daily, or as prescribed by a physician.
General Statements: All Other Content
How supplied: Unit Dose blister packs, 10 capsules per card, orange/brown capsules imprinted B-203.
Precautions re: Children
Keep this and all medications out of the reach of children.
Storage
Store at 25(0)C (77(0)F); excursions permitted to 15(0)-30(0)C (59(0)-86(0)F). See USP Controlled Room Temperature.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.